FDA

The richest man in the world is emerging, along with Robert F. Kennedy or the ultra anti-immigration adviser Stephen Miller, as one of the potential collaborators of the White House’s next tenant

The new monoclonal antibody lecanemab has been greenlighted by the US and other countries, but the European Medicines Agency considers that the benefits do not outweigh the risks

Researchers from the universities of Zurich, Yale and Harvard reveal the differences between the characteristics of the patients who receive the drug during pharmaceutical testing and those who end up receiving it, which may reduce its safety and efficacy

The justices must decide whether to increase restrictions on drug that is used in more than half of all pregnancy terminations in the country

The central dispute in the case is whether the Food and Drug Administration overlooked serious safety problems when it made mifepristone easier to obtain, including through mail-order pharmacies

A legislative reform being prepared by the European Union plans to promote the use of already approved drugs to treat other illnesses. Doing so will speed up the approval of treatments and save on research costs

After half-a-century of prohibition, the United States is about to legalize psilocybin and MDMA for clinical use, to treat people suffering from post-traumatic stress disorder or terminal cancer. Scientists, patients, clandestine therapists and war veterans speak with EL PAÍS about the bright spots and shadows of this rebirth

The controversial entrepreneur announced his company’s product will be called Telepathy, and will allow patients to control a cell phone and a computer with their mind

The economic impact of obesity will reach losses of up to $4 trillion by 20235, or 3% of global GDP

Some experts worry the U.S. may be repeating mistakes that gave rise to the opioid crisis: overprescribing a questionable drug that carries significant safety and abuse risks

The experts consulted see the approval of the use of zuranolone as good news, but they also point out that we must not lose focus on the many other aspects that surround a mother and her baby

The panel of Food and Drug Administration experts met Wednesday to review a stem cell-based therapy that has been at the center of a yearslong lobbying campaign by patients

The tycoon’s biotech company is currently looking for human volunteers to test its implants, which have allowed animals to control external devices with their minds

A team of scientists has managed to prevent neuronal death with oral drugs administered to rodents that have been genetically modified to imitate dementia

The Food and Drug Administration decision opens the newest shots from Moderna and Pfizer and its partner BioNTech to most Americans even if they’ve never had a coronavirus vaccination

The decision by three judges on the 5th U.S. Circuit Court of Appeals in New Orleans overturned part of a lower court ruling that would have revoked the Food and Drug Administration’s 23-year-old approval of mifepristone

All of the recalled cookies, soup and falafel have been removed from sale or destroyed, Trader Joe’s said in its announcements

While the USDA just approved two companies that produce lab-grown meat, Italy, as a precaution, banned its production and sale

The Food and Drug Administration on Monday approved the injection for infants and children up to 2 years old. It’s made by AstraZeneca and is already approved in Canada and Europe

Medical societies and women’s health groups have pushed for wider access for decades, noting that an estimated 45% of the 6 million annual pregnancies in the U.S. are unintended

The decision means that the treatment, which modestly slows down the advance of the brain-robbing disease, should be covered under the U.S. health insurance program

The number of different electronic cigarette devices sold in the U.S. has nearly tripled to over 9,000 since 2020, driven almost entirely by a wave of unauthorized disposable vapes from China

The Food and Drug Administration’s scientific advisers said the next round of shots in the U.S. should only include protection against the newest variants that are now dominant worldwide

The decision carries extra significance because insurers have held off on paying for the drug, Leqembi, until it has full FDA approval

The drugmaker is seeking to halt the program, which was laid out in the Inflation Reduction Act and is expected to save taxpayers billions of dollars in the coming years

The drug is similar to naloxone, the life-saving drug that has been used for decades to quickly reverse overdoses caused by opioids